Currently, biomarker cancer antigen 125 is used as a diagnostic tool; however, it lacks specificity, as elevated levels can occur in various conditions such as endometriosis, liver disease, leiomyoma, and pelvic inflammatory disease (The CA125 blood test for ovarian cancer has been re-evaluated). This evidence concerns the gene MUC16 and pelvic inflammatory disease.